RICHARD WAGNER: Open Payments
NPI 1184868598 · JANESVILLE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,740 in 57 payments from 10 companies in 2025. Trend: 2023 $247 · 2024 $1,335 · 2025 $1,740
Food & beverage: $1,740
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 11 | $363 |
| E.R. Squibb & Sons, L.L.C. | 12 | $341 |
| ABBVIE INC. | 11 | $312 |
| Teva Pharmaceuticals USA, Inc. | 5 | $187 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $180 |
| Janssen Pharmaceuticals, Inc | 5 | $115 |
| Neurocrine BioSciences, Inc. | 4 | $92 |
| Axsome Therapeutics, Inc. | 1 | $87 |
| Corium, LLC | 3 | $38 |
| Lundbeck LLC | 1 | $26 |
Products named: COBENFY, VRAYLAR, REXULTI, CAPLYTA, UZEDY, ABILIFY MAINTENA, INGREZZA, INVEGA SUSTENNA.
Industry payments across WI — which companies pay providers there.
